US2951838A - Novel method of preparing nucleotide imidazoles - Google Patents

Novel method of preparing nucleotide imidazoles Download PDF

Info

Publication number
US2951838A
US2951838A US862788A US86278859A US2951838A US 2951838 A US2951838 A US 2951838A US 862788 A US862788 A US 862788A US 86278859 A US86278859 A US 86278859A US 2951838 A US2951838 A US 2951838A
Authority
US
United States
Prior art keywords
nucleotide
adenosine
imidazoles
novel method
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US862788A
Inventor
Goldman Leon
Marsico Joseph William
Anderson George Washington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to US862788A priority Critical patent/US2951838A/en
Application granted granted Critical
Publication of US2951838A publication Critical patent/US2951838A/en
Priority to GB39893/60A priority patent/GB935508A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Definitions

  • nucleoside is used herein to include deoxynucleosides.
  • nucleoside within the meaning of the present invention includes:
  • Thymidine or thymine deoxyriboside
  • a nucleotide is a phosphate ester of a nucleoside and maybe a nucleoside monophosphate gor a nucleoside polyphosphate.
  • nucleoside monophosphates are:
  • Adenosine-5' phosphate or muscle adenylic acid or adenosine monophosphate, the latter hereinafter termed AMP: "i
  • nucleoside polyphosphates are: (1) Adenosine-S diphosphate (hereinafter termed ADP):
  • ATP Adenosine-S' 'triphosphate
  • a nucleotide coenzyme is a compound including in its structure at least one simple nucleotide moiety.
  • the term nucleotide coenzyme is applied to a large and growing group of substances which are vital components of many enzyme systems involved in metabolic processes. Nucleotide coenzymes functionin association with specific proteins or apoenzymes, the complete enzyme system being made up of the combination ajpoenzyme plus coenzyme. Historically, the first nucleotide coenzyme discovered was cozymase, or diphosphopyridine nucleotide, discovered by Harden and Young in 1904. Examples ofi nucleotide coenzymes are:
  • Cozymase or diphosphopyridine nucleotide
  • phosphate may condense, giving the undesired symmetrical pyrophosphate
  • nucleotide imidazoles may be prepared in good yield by the treatment of a salt of a nucleotide with a 1,1-carbonyldiimidazole as set forth in the following reaction scheme:
  • H R R wherein the Base is either a purine or a pyrimidine moiety, the Sugar is either a pentose or a hexose moiety such as, for example, D-ribose, D-glucose, or 2-deoxy-D- ribose, R is vinylene, substituted-vinylene, o-phenylene, or substituted-o-phenylene, R is hydrogen or lower alkyl, and B is an organic base such as, for example, imidazole, pyridine, or trioctyl amine.
  • the Base is either a purine or a pyrimidine moiety
  • the Sugar is either a pentose or a hexose moiety such as, for example, D-ribose, D-glucose, or 2-deoxy-D- ribose
  • R is vinylene, substituted-vinylene, o-phenylene, or substituted-o-phenylene
  • R
  • the 1,1-carbonyldiimidazole reagent employed may be, for example, 1,1-carbonyldiimidazole, 1,1-carbonyldi(2-methyl) -imidazole, 1,1 carbonyldi(4 methyl)imidazole, 1,1 carbonyldibenzimidazole, 1,1 carbonyldi(4-nitro)benzirnidaziole, 1,1' carbonyldi(6 nitro) benzimidazole, and the like.
  • the reaction may be carried out in nonaqueous solvents such as, for example, formamide N,N-dimethylformamide, dimethyl sulfoxide, acetontitrile, pyridine, diethyl phosphite, morpholine, dioxane, 1,2-dimethoxyethane, and the like.
  • the reaction is ordinarily carried out at temperatures not substantially exceeding room temperature and over periods of time ranging from less than one minute to an hour or more.
  • Carbon dioxide and an imidazole are the only by-products of the reaction, and it is an advantage of the novel method of the present invention that both by-products are easily separated from the final reaction mixture.
  • the principal advantage of the novel method of the present invention is that it is superior to the previously known method of preparing nucleotide imidazoles insofar as facility of manipulation is concerned.
  • nucleotide coenzymes and related compounds such as the linear and cyclic oligonucleotides from the nucleotide imidazoles in the presence of water as a solvent without the starting material reacting with that solvent.
  • Ultraviolet absorbing spots were observed corresponding to a major amount of adenosine-S' phosphoroimidazole and a very minor amount of unchanged adenosine-5' phosphate.
  • An additional spot corresponding to adenosine-S' phosphoroamidate was observed, this having been formed by the action of ammonia on adenosine-S' phosphoroimidazole during the chromatographic process.
  • spots appeared corresponding to adenosine-S phosphoroimidazole and imidazole.
  • EXAMPLE 2 Preparation of adenosine-S' phosphoroimidazole To a stirred solution of 1 mole of adenosine-S' phosphate hydrate and 3.14 moles of imidazole in anhydrous dimethylforrnamide, cooled to 0' C. to 5 C., was added 2 moles of 1,1-carbony1diimidazole. After 5 minutes the mixture was cooled to -10 C. to --20 C. and stirred for an additional 10 minutes.
  • Paper chromatography in isopropyl alcohol-1% ammonium sulfate (21) showed the reaction mixture to contain mainly adenosine-S' phosphoroimidazole along with a small amount of unreacted adenosine-S' phosphate.
  • Chromatography in isopropyl alcohol-ammonia-water (7--1-2) confirmed the above.
  • EXAMPLE 3 Preparation of adenosine-S' phosphoroimidazole To a stirred solution of 1.00 g. of adenosine-S' phosphate hydrate and 0.586 g. of imidazole in 7.5 ml. of anhydrous dimethylformarnide at room temperature was added 1.486 g. of 93% 1,1-carbonyldiimidazole, and after 15 minutes the resulting solution was analyzed by paper chromatography in isopropyl alcohol-ammonia-water (7-1-2), showing complete conversion of adenosine-S' phosphate to adenosine-S' phosphoroimidazole.
  • nucleotide imidazoles which comprises treating a salt of a nucleotide and an organic base with a compound of the formula:
  • R is selected from the group consisting of vinylene, lower alkyl substituted vinylene, o-phenylene and mono-nitro substituted o-phenylene, and R is selected 2,951,838 .r 7 a from the group consisting of hydrogen and lower alkyl. benzimidazole and 1,1'-carbonyldi(6-nitro)benzimidazole.
  • the method of preparing nucleotide imidazoles 3.
  • the method of preparing adenosine-Yphosphoro which comprises treating a salt of a nucleotide and an imidazole which comprises treating the salt imidazole organic base with a compound selected from the group adenosine-S phosphate with 1,1-carbonyldi-imidazole in consisting of 1,1-carbonyldiimidazo1e, 1,1'-carbonyldi(2- 5 an inert solvent at a temperature between -20 C. and methyDimidazole, 1,1'-carbonyldi(4 methyl)irnidazole, +30 C. 1,1 carbonyldibenzimidazole, 1,1 carbonyldi(4-nitro) No references cited.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Description

NOVEL METHOD OF PREPARING NUCLEOTIDE IMIDAZOLES Leon Goldman and Joseph William Marsico, Nanuet,
N.Y.,yand George Washington Anderson, Upper Saddle River,vN.J., assignors to American Cyanamid Company, New York, N.Y., a corporation of Maine No Drawing. Filed Dec. 30, 1959, Ser. No. 862,788
3 Claims. (Cl. 260 211.5)
IfNTN\ CHnOH (2) Guanosine (or guanine riboside):
(3) Cytidine (or cytosine riboside):
CHzOH The termnucleoside is used herein to include deoxynucleosides. Thus, nucleoside within the meaning of the present invention includes:
' i United States Patent O Patented Sept. 6, 1960 ice 2 (4) Thymidine (or thymine deoxyriboside):
N CHzOH 0 f N OH;
A nucleotide is a phosphate ester of a nucleoside and maybe a nucleoside monophosphate gor a nucleoside polyphosphate. Examples of nucleoside monophosphates are:
(1) Adenosine-5' phosphate (or muscle adenylic acid or adenosine monophosphate, the latter hereinafter termed AMP): "i
l H H t N N omo-r-oi'z 1/ (2) Guanosine-S' phosphate:
N N- CH O] -OH Hm i T 2 l (3) Cytidine-S' phosphate:
n r N 01110-1 -011 f y H (4) Thymidine-S phosphate:
, omo-r-on 3 Examples of nucleoside polyphosphates are: (1) Adenosine-S diphosphate (hereinafter termed ADP):
II II cmo-r-o-r-on '(2) Adenosine-S' 'triphosphate (hereinafter termed ATP):
A nucleotide coenzyme is a compound including in its structure at least one simple nucleotide moiety. The term nucleotide coenzyme is applied to a large and growing group of substances which are vital components of many enzyme systems involved in metabolic processes. Nucleotide coenzymes functionin association with specific proteins or apoenzymes, the complete enzyme system being made up of the combination ajpoenzyme plus coenzyme. Historically, the first nucleotide coenzyme discovered was cozymase, or diphosphopyridine nucleotide, discovered by Harden and Young in 1904. Examples ofi nucleotide coenzymes are:
(1) Cozymase (or diphosphopyridine nucleotide):
on OH 4 (3) Uridine diphosphate glucose:
u l N O-H'zOP-'O--'PO OH r I OH H t N (4) Coenzyme A:
II H OK i N N H10-P-0-P-0oHrb-( JH- -NH I OH H H: H: N N/ H: v HS-CH2CHPHN-3=D The reaction of adenosine-S' phosphate, dicyclo-hexylcarbodiimide and imidazole was recently examined by R. W. Chambers and I. G. Molfatt [J. Am. Chem. Soc.
80, 3752 (1958)]. There are obtained 1,3-dicyclohexylurea and adenosine-S' phosphoroimidazole as set forth in the following reaction scheme:
phosphate may condense, giving the undesired symmetrical pyrophosphate;
The following examples illustrate the novel method of preparing nucleotide imidazoles of the present invention.
thus wasting starting material and complicating the isolation procedure: and (b) the incidentally formed dialkyl urea must be removed, an additional isolation requirement.
Our invention is based upon the discovery that nucleotide imidazoles may be prepared in good yield by the treatment of a salt of a nucleotide with a 1,1-carbonyldiimidazole as set forth in the following reaction scheme:
H R R wherein the Base is either a purine or a pyrimidine moiety, the Sugar is either a pentose or a hexose moiety such as, for example, D-ribose, D-glucose, or 2-deoxy-D- ribose, R is vinylene, substituted-vinylene, o-phenylene, or substituted-o-phenylene, R is hydrogen or lower alkyl, and B is an organic base such as, for example, imidazole, pyridine, or trioctyl amine.
In carrying out the novel method of the present invention for preparing nucleotide imidazoles, the 1,1-carbonyldiimidazole reagent employed may be, for example, 1,1-carbonyldiimidazole, 1,1-carbonyldi(2-methyl) -imidazole, 1,1 carbonyldi(4 methyl)imidazole, 1,1 carbonyldibenzimidazole, 1,1 carbonyldi(4-nitro)benzirnidaziole, 1,1' carbonyldi(6 nitro) benzimidazole, and the like. The reaction may be carried out in nonaqueous solvents such as, for example, formamide N,N-dimethylformamide, dimethyl sulfoxide, acetontitrile, pyridine, diethyl phosphite, morpholine, dioxane, 1,2-dimethoxyethane, and the like. The reaction is ordinarily carried out at temperatures not substantially exceeding room temperature and over periods of time ranging from less than one minute to an hour or more. Carbon dioxide and an imidazole are the only by-products of the reaction, and it is an advantage of the novel method of the present invention that both by-products are easily separated from the final reaction mixture. The principal advantage of the novel method of the present invention, however, is that it is superior to the previously known method of preparing nucleotide imidazoles insofar as facility of manipulation is concerned.
The reactivity of phosphorylated imidazoles is much greater than that of the ordinary phosphoramidates which also contain a phosphorus-nitrogen linkage. Surprising- 1y, however, although the phosphorus-nitrogen bond in the nucleotide imidazoles is thus generally activated, it is nevertheless resistant to reaction with water. Hence, it is possible to prepare nucleotide coenzymes and related compounds such as the linear and cyclic oligonucleotides from the nucleotide imidazoles in the presence of water as a solvent without the starting material reacting with that solvent. This circumstance is of critical importance because water is the most convenient solvent for nucleo- EXAMPLE 1 Preparation of adenosine-5' phosphor-oimidazole To a solution of 1 mole of adenosine-S" phosphate hydrate and 3 moles of imidazole in anhydrous dimethylformamide at room temperature Was added 2 moles of 1,1-carbonyldiimidazole with stirring. Carbon dioxide was immediately evolved, with the formation of adenosine-5 phosphoroimidazole in solution. This was shown by paper chromatography in isopropyl alcohol-ammonia water (7l--2) of aliquots taken after 2,5, and 20 minutes. Ultraviolet absorbing spots were observed corresponding to a major amount of adenosine-S' phosphoroimidazole and a very minor amount of unchanged adenosine-5' phosphate. An additional spot corresponding to adenosine-S' phosphoroamidate was observed, this having been formed by the action of ammonia on adenosine-S' phosphoroimidazole during the chromatographic process. When the chromatogram was sprayed with imidazole detecting reagent, spots appeared corresponding to adenosine-S phosphoroimidazole and imidazole.
EXAMPLE 2 Preparation of adenosine-S' phosphoroimidazole To a stirred solution of 1 mole of adenosine-S' phosphate hydrate and 3.14 moles of imidazole in anhydrous dimethylforrnamide, cooled to 0' C. to 5 C., was added 2 moles of 1,1-carbony1diimidazole. After 5 minutes the mixture was cooled to -10 C. to --20 C. and stirred for an additional 10 minutes. Paper chromatography in isopropyl alcohol-1% ammonium sulfate (21) showed the reaction mixture to contain mainly adenosine-S' phosphoroimidazole along with a small amount of unreacted adenosine-S' phosphate. Chromatography in isopropyl alcohol-ammonia-water (7--1-2) confirmed the above. An additional spot corresponding to adenosine-S phosphoroamidate arose from ammonolysis of adenosine-S' phosphoroimidazole during the chromatographic process.
EXAMPLE 3 Preparation of adenosine-S' phosphoroimidazole To a stirred solution of 1.00 g. of adenosine-S' phosphate hydrate and 0.586 g. of imidazole in 7.5 ml. of anhydrous dimethylformarnide at room temperature was added 1.486 g. of 93% 1,1-carbonyldiimidazole, and after 15 minutes the resulting solution was analyzed by paper chromatography in isopropyl alcohol-ammonia-water (7-1-2), showing complete conversion of adenosine-S' phosphate to adenosine-S' phosphoroimidazole.
We claim:
1. The method of preparing nucleotide imidazoles which comprises treating a salt of a nucleotide and an organic base with a compound of the formula:
wherein R is selected from the group consisting of vinylene, lower alkyl substituted vinylene, o-phenylene and mono-nitro substituted o-phenylene, and R is selected 2,951,838 .r 7 a from the group consisting of hydrogen and lower alkyl. benzimidazole and 1,1'-carbonyldi(6-nitro)benzimidazole.
2. The method of preparing nucleotide imidazoles 3. The method of preparing adenosine-Yphosphorowhich comprises treating a salt of a nucleotide and an imidazole which comprises treating the salt imidazole organic base with a compound selected from the group adenosine-S phosphate with 1,1-carbonyldi-imidazole in consisting of 1,1-carbonyldiimidazo1e, 1,1'-carbonyldi(2- 5 an inert solvent at a temperature between -20 C. and methyDimidazole, 1,1'-carbonyldi(4 methyl)irnidazole, +30 C. 1,1 carbonyldibenzimidazole, 1,1 carbonyldi(4-nitro) No references cited.

Claims (1)

1. THE METHOD OF PREPARING NUCLEOTIDE IMIDAZOLES WHICH COMPRISES TREATING A SALT OF A NUCLEOTIDE AND AN ORGANIC BASE WITH A COMPOUND OF THE FORMULA:
US862788A 1959-12-30 1959-12-30 Novel method of preparing nucleotide imidazoles Expired - Lifetime US2951838A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US862788A US2951838A (en) 1959-12-30 1959-12-30 Novel method of preparing nucleotide imidazoles
GB39893/60A GB935508A (en) 1959-12-30 1960-11-21 Nucleotide imidazoles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US862788A US2951838A (en) 1959-12-30 1959-12-30 Novel method of preparing nucleotide imidazoles

Publications (1)

Publication Number Publication Date
US2951838A true US2951838A (en) 1960-09-06

Family

ID=25339353

Family Applications (1)

Application Number Title Priority Date Filing Date
US862788A Expired - Lifetime US2951838A (en) 1959-12-30 1959-12-30 Novel method of preparing nucleotide imidazoles

Country Status (2)

Country Link
US (1) US2951838A (en)
GB (1) GB935508A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544741A (en) * 1982-03-29 1985-10-01 Robins Roland K Azole dinucleotide compounds and methods for their production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544741A (en) * 1982-03-29 1985-10-01 Robins Roland K Azole dinucleotide compounds and methods for their production

Also Published As

Publication number Publication date
GB935508A (en) 1963-08-28

Similar Documents

Publication Publication Date Title
JP2705914B2 (en) New polynucleotide
Prisbe et al. Halo sugar nucleosides. V. Synthesis of angustmycin A and some base analogues
US3201389A (en) Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
US5733896A (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
Marumoto et al. Synthesis and coronary vasodilating activity of 2-substituted adenosines
US3321462A (en) Process for the preparation of nucleoside polyphosphates
EP0173059B1 (en) Method for the production of 2'-deoxyadenosine compounds
Verheyden et al. Halosugar nucleosides. II. Iodination of secondary hydroxyl groups of nucleosides with methyltriphenoxyphosphonium iodide
US4663446A (en) N2 (phenyl substituted) deoxy guanosine containing compounds
US3534017A (en) Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates
Ueda et al. Synthesis of 6-Thioguanine and 2, 6-Diaminopurine Nucleosides and Nucleotides from Adenine Counterparts via a Facile Rearrangement in the Base Portion (Nucleosides and Nucleotides. XIX)
US3928319A (en) 4 -Fluoro nucleosides, novel intermediates and methods of preparing same
US8288545B2 (en) Reactive pyrophosphoric and bisphosphonic acid derivatives and methods of their use
US4728730A (en) Synthesis of nucleoside thiophosphoanhydrides
US2951838A (en) Novel method of preparing nucleotide imidazoles
Seita et al. The synthesis of nucleoside and nucleotide analogs
US3201388A (en) Method of preparing 5'-ribonucleotides
US3082203A (en) Novel nucleotide coenzymes
CA1060004A (en) 1-(beta-d-ribofuranosyl)-1,2,4-triazole acid esters
US3541079A (en) Process for the manufacture of nucleosides
CS270235B2 (en) Method of carbocyclic purine nicleotides preparation
Hall et al. Nucleotides of 2-(2'-Deoxy-D-ribofuranosyl)-6-methyl-asym-triazine-3, 5 (2, 4)-dione (Azathymidine)
Matulic-Adamic et al. A Simple Multi-Gram Synthesis of 5′-Hydrogenphosphonates and 5′-Phosphorofluoridates of Sugar Modified Nucleosides
Spassova et al. Ribonucleosides of 3-amino-and 3, 5-diaminopyrazole-4-carboxylic acid and their open-chain analogues: Synthesis and reactions
Visser et al. Synthesis of 3′‐amino‐3′‐deoxyadenosine 5′‐triphosphate